Status:
UNKNOWN
Perifoveal Vascular Network Assessed by OCT-Angiography in Type I Diabetes Mellitus
Lead Sponsor:
Hospital Clinic of Barcelona
Collaborating Sponsors:
Fundació La Marató de TV3
Conditions:
Retinal Vascular
Retinal Disease
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
This study is directed to evaluate the role of Optical Coherence Tomography Angiography (OCT-A) in the evaluation of the perifoveal vascular network in type 1 diabetic patients, and to investigate the...
Detailed Description
Diabetic retinopathy (DR) is the leading cause of blindness in type 1 Diabetes Mellitus (DM) patients, as a consequence of impaired blood flow in the retina. Optical coherence tomography angiography (...
Eligibility Criteria
Inclusion
- Type 1 Diabetes Mellitus
- Healthy controls
Exclusion
- Ocular pathologies other than diabetic retinopathy (i.e. age-related macular degeneration, retinal vein occlusions, uveitis, glaucoma, etc.)
- Axial length: \<-6.00 to \>+3.00 diopters
- Media Opacities
- Unability to capture OCT images
Key Trial Info
Start Date :
May 8 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2021
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT03422965
Start Date
May 8 2017
End Date
May 31 2021
Last Update
July 29 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Clinic de Oftalmologia (ICOF), Hospital Clínic de Barcelona
Barcelona, Spain, 08028
2
Diabetes Unit, Institut Clinic de Malalties Digestives i Métaboliques (ICMDM), Hospital Clínic de Barcelona
Barcelona, Spain, 08036